Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
It's an unpredictable mess, and it introduces a massive variable into your work
The Precision Peptide Company Applauds FDA Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8-6 (one abstention) to recommend BPC-157 for inclusion on the Section 503A Bulks List
The compound's development represents years of medicinal chemistry optimization, resulting in a 10-fold improvement in potency over parent compounds while maintaining excellent safety margins in preclinical studies
POTENT ANTI-INFLAMMATORY EFFECTS
US$ 26.10
US$ 28.56
US$ 23.87
US$ 23.66
US$ 23.91
US$ 29.46
US$ 29.05
US$ 21.52
